MedTrace Logo

Impact of Germicidal Light

NCT03886337 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2020-03-05

No results posted yet for this study

Summary

Visible light at 405nm has been shown to be germicidal. The hypothesis is that use of this light (Indigo-Clean Lights) in operating rooms will reduce S. aureus transmission occurring within and between patients and reduce surgical site infections (SSIs). Investigators will evaluate a case-control study where patients undergoing surgery with the lights are matched with patients undergoing surgery without germicidal lights.

Conditions

  • Bacterial Transmission
  • S.Aureus Transmission
  • Operating Room Exposure to S. Aureus
  • 90-day Postoperative Surgical Site Infections, Superficial and Deep

Interventions

DEVICE

Germicidal lighting

Germicidal ambient lighting

Sponsors & Collaborators

  • Kenall Manufacturing

    collaborator OTHER

  • University of Iowa

    lead OTHER

Principal Investigators

  • Randy W. Loftus, MD · University of Iowa

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-01
Primary Completion
2024-12-31
Completion
2024-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03886337 on ClinicalTrials.gov